02175-A: Development of a Brucellosis Vaccine for Dogs
Grant Status: Open
AbstractBrucella infections constitute a serious problem for dog breeders, pet owners, and kennels, leading not only to economic costs associated with reproductive loss, but also a public health concern because of the zoonotic potential. The disease, once established, is difficult to control due to the lack of a protective vaccine for canine use. Historically, brucellosis control efforts have demonstrated that the spread of the disease is preventable or significantly reduced in association with vaccination. Unfortunately, efforts to develop a brucellosis vaccine that is safe and effective for dogs have been unsuccessful to date. The goal of this research is to develop a safe and efficacious Brucella canis vaccine using a genetic mutant that has been shown to be safe and efficacious for controlling infection against other Brucella species. The development of a safe and highly protective brucellosis vaccine for dogs will significantly impact canine and human health by limiting the spread of disease.
None at this time.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.